Search

everythinglearnresearchcommunity

for

Search:↓

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Accurate diagnosis is crucial for effective treatment of hair loss.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The article explains how to diagnose and manage certain types of scarring hair loss.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Alopecia causes hair loss and should be treated early, especially scarring types where hair cannot regrow.

Hair transplants can work for permanent hair loss if the condition is stable and done carefully.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.